The news that pharmacy-benefits manager Express Scripts is ditching the world's biggest diabetes-focused company came as a surprise. It will no longer use Novo Nordisk's Victoza, or any of its ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Editor's note: An earlier version of this story incorrectly stated that a specific type of insulin was excluded from CVS 2017 ...

Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month under a plan announced Wednesday. The move is aimed at addressing ...